Helga Refsum

Title: Helga Refsum: Innovator in Cognitive Health

Introduction

Helga Refsum is a distinguished inventor based in Oxford, GB. She has made significant contributions to the field of cognitive health, particularly through her innovative therapies aimed at treating cognitive impairment disorders. With a total of 3 patents to her name, Refsum's work is paving the way for new treatment options for conditions such as Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD).

Latest Patents

One of her latest patents focuses on a combination therapy that includes an omega-3 fatty acid, a folate species, and a vitamin B12 species. This invention provides a combined therapy that utilizes one or more omega-3 fatty acids along with B vitamins to treat cognitive impairment. The therapy is designed for individuals suffering from cognitive impairment disorders, particularly those resulting from brain or cerebral atrophy. The invention encompasses methods for treating and reducing the progression of brain atrophy, along with pharmaceutical compositions and nutritional supplements.

Career Highlights

Helga Refsum has worked with notable organizations such as Oxford University Innovation Limited and Isis Innovation Limited. Her career reflects a commitment to advancing research and development in cognitive health, contributing to the scientific community's understanding of effective treatment methodologies.

Collaborations

Throughout her career, Refsum has collaborated with esteemed colleagues, including David Anthony Smith and Fredrik Jerneren. These partnerships have further enriched her research and innovation efforts.

Conclusion

Helga Refsum's contributions to cognitive health through her innovative therapies highlight her role as a leading inventor in the field. Her work continues to inspire advancements in treatment options for cognitive impairment disorders.